Study on the Treatment of Benign Prostate Hyperplasia Combined with Underactive Bladder Detrusor Contraction by Transurethral Plasma Enucleation of the Prostate

Objective: Exploring the clinical efficacy of transurethral plasma enucleation prostate in treatment benign prostatic hyperplasia with underactive bladder detrusor contractility. Methods: Retrospective analysis data 68 patients and muscle contractility treated by our department from July 2021 to 2022. The above all met diagnosis hyperplasia, excluding cancer urethral stricture. Urodynamics showed a decrease contractile force muscle, surgical equipment used Olympus bipolar resection method. Divide into two groups: experimental group 34 who underwent control prostate. Evaluate preoperative baseline level postoperative observation indicators groups patients, compare statistical differences between groups. Results: Both successfully completed surgery, there were no serious complications such as rectal or perforation during less bleeding. QOL, IPSS, Qmax, residual urine volume undergoing significantly improved compared those before surgery (P 0.05). Conclusion: Transurethral has good safety combined weakened Compared traditional electric is more significant. In terms main although are slightly temporary urinary incontinence after enucleation, statistically significant difference resection, they can recover normal short term.